As coronavirus pandemic worsens, health officials fear nationalization of drugs and supplies
An allegation that the Trump administration tried to secure exclusive rights to the production of an experimental coronavirus vaccine in Germany has revived health officials’ concerns that countries worldwide might move to nationalize key supplies to respond to the growing pandemic.
The allegation, first reported on Sunday in German media and later echoed by the nation’s health minister, centered on the suggestion that the Trump administration sought to strike a deal with CureVac, a drug maker that is based in the city of Tübingen but that also has operations in the United States.
